U.S. markets open in 1 hour 38 minutes
  • S&P Futures

    4,244.25
    -42.25 (-0.99%)
     
  • Dow Futures

    33,710.00
    -271.00 (-0.80%)
     
  • Nasdaq Futures

    13,374.25
    -149.00 (-1.10%)
     
  • Russell 2000 Futures

    1,977.50
    -24.20 (-1.21%)
     
  • Crude Oil

    88.44
    -2.06 (-2.28%)
     
  • Gold

    1,764.80
    -6.40 (-0.36%)
     
  • Silver

    19.16
    -0.30 (-1.56%)
     
  • EUR/USD

    1.0052
    -0.0040 (-0.39%)
     
  • 10-Yr Bond

    2.8800
    0.0000 (0.00%)
     
  • Vix

    20.87
    +0.97 (+4.87%)
     
  • GBP/USD

    1.1820
    -0.0112 (-0.94%)
     
  • USD/JPY

    137.0680
    +1.2060 (+0.89%)
     
  • BTC-USD

    21,470.73
    -2,040.33 (-8.68%)
     
  • CMC Crypto 200

    510.07
    -47.66 (-8.55%)
     
  • FTSE 100

    7,551.07
    +9.22 (+0.12%)
     
  • Nikkei 225

    28,930.33
    -11.81 (-0.04%)
     

General Dynamics (GD) Wins $696M Deal to Aid C-20 & C-37 Jets

  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

General Dynamics Corp.’s GD subsidiary, Gulfstream Aerospace, recently secured a contract, involving the C-20 and C-37 aircraft. The deal has been awarded by the U.S. Air Force Life Cycle Management Center.

Valued at $696 million, the contract’s engineering services part represents a $612 million deal, while contractor logistics support (CLS) is worth $84 million. This brings the cumulative face value of the contract to $594 million.

Per the terms, Gulfstream will offer engineering services, aircraft modifications, configuration management, data delivery and publication management.

Brief Note on C-20 & C-37 Jets

The C-20 is a military version of the Gulfstream IV aircraft, which are capable of all-weather, long-range, high-speed, nonstop transoceanic flights. On the other hand, C-37A is a military version of the Gulfstream V, while C-37B is a military version of the Gulfstream 550 aircraft. These are low-wing jets powered by two turbofan engines equipped with thrust reversers capable of all-weather, long-range, and high-speed nonstop flights.

Rising Demand for Combat Jets Aids Gulfstream

With growing security threats across the globe, emerging economies like the Asia Pacific, the Middle East and South America are spending a lot on enhancing their defense arsenals. Meanwhile, developed nations like the United States and Europe have already been leading the defense market for some time now.

It is imperative to mention in this context that military aircraft form an integral constituent of a country’s defense products. Notably, emerging trends in the combat aircraft space like turbofan engines equipped with thrust reversers like that found in C-20 and C-37, along with advanced composite materials and stealth technology have been driving demand substantially.

Being one of the prominent jet makers in the United States, Gulfstream thus enjoys a smooth flow of contracts for military jets and its associated upgrades. The latest contract win is an example of the same.

Looking Ahead

Per a Morder Intelligence report, the global combat aircraft market is expected to witness CAGR of 4% during the 2020-2025 time period. Such growth can be attributed to increasing global threats, geopolitical instabilities and higher spending on defense. These projections should benefit combat jet manufacturers like General Dynamics, Boeing BA, Northrop Grumman NOC and Lockheed Martin LMT.

Price Performance

In a year’s time, shares of General Dynamics have gained 30.4% compared with the industry’s rise of 22.1%.

Zacks Rank

General Dynamics currently carries a Zacks Rank #5 (Strong Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>




Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Northrop Grumman Corporation (NOC) : Free Stock Analysis Report

The Boeing Company (BA) : Free Stock Analysis Report

General Dynamics Corporation (GD) : Free Stock Analysis Report

Lockheed Martin Corporation (LMT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research